Tag Archives: clinical trials

New Target for Alzheimer’s Disease

shutterstock_27160801

Biotechnologists have developed a drug candidate that blocks production of diseasecausing neurotoxins in mouse models Reducing the concentration of cathepsin B using an enzyme inhibitor prevents the creation of the neurotoxic peptide, pyroglutamate-AB (pGlu-AB), which has been linked to the development of Alzheimer’s disease (AD). The candidate inhibitor drug, a cysteine protease inhibitor named E64d, was developed by scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Syringes for Clinical Trials

lab_tech02

Today’s pharmaceutical and biotechnology companies are under pressure to remain competitive. To do so, they require innovative approaches to manage drug development, particularly early development work. Any competitive advantage in the development process is highly prized – and one approach is to begin the development of the compound in a prefilled syringe earlier in the process, rather than later. Traditionally, biopharmaceutical companies have almost exclusively used vials in drug development. There are good reasons for Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

New Type of Prospective Survey Initiative

scientist-eyedropper

Our industry is on the cutting-edge of science aimed at developing new therapies for devastating and life-threatening diseases. To help advance innovation and promote the development of the next generation of treatments and cures, we must acknowledge that the scientific method does not operate in a vacuum. Robust, interactive FDA-Sponsor communication is a key element of modern drug development. However, in order to improve the drug development enterprise and the FDA review process further, the Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BioNJ Streamlines Clinical Trials Agreement Process

bionj3

Biotechnology companies face monumental challenges – from containing R&D costs to managing sales and marketing to compliance with regulatory bodies. Biotech startups often operate with just a few employees, all of whom tend to pull double duty, both in the lab and front office. With that in mind, BioNJ has produced a free document available to companies (not just New Jersey-based ) interested in streamlining the often time-consuming process of negotiating clinical trial agreements. The Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

Life Science Leader on TransCelerate’s Efforts to Modernize Drug Development

TransCelerate Dalvir Gill

Life Science Leader’s Rob Wright has a great profile on TransCelerate BioPharma and their efforts to modernize the drug development and clinical trial landscape. TransCelerate is a nonprofit organization made up of 18 innovate biopharmaceutical companies dedicated to collaborating across the industry to find ways to simplify and accelerate the discovery of new medicines. As the article notes, the challenge involved is enormous: With combined annual revenues in excess of $300 billion and nearly 800,000 employees Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,